Here's a Biotech IPO You Don’t Want To Miss
Published: Jan 09, 2017
You might be too busy to pay much attention to every tiny biotech that goes public. There's one initial public offering (IPO) coming up, though, that I think you'll want to keep your eyes on. Jounce Therapeutics filed a few days ago for an IPO in 2017. Any company that Celgene (NASDAQ:CELG) is willing to invest in big-time is one that is worth watching.